LONG-TERM TREATMENT WITH SUBCUTANEOUS VEDOLIZUMAB IN CROHN’S DISEASE: INTERIM RESULTS FROM THE VISIBLE OPEN-LABEL EXTENSION STUDY

Silvio Danese  ¹     Severine Vermeire  ²     Krisztina Kisfalvi  ³     Wenwen Zhang     Shashi Adsul  ⁴     Siddharth Bhatia     William Sandborn  ^5    
1 Humanitas Research Hospital and Humanitas University, Milan, Italy
² University Hospital Leuven, Leuven, Belgium
³ Takeda, Cambridge, United States
⁴ Takeda, Zurich, Switzerland
⁵ University of California San Diego, La Jolla, United States

Session
IBD: Clinical trials poster I

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)